112 related articles for article (PubMed ID: 23432595)
1. Sulfonamide-metal complexes endowed with potent anti-Trypanosoma cruzi activity.
Chohan ZH; Hernandes MZ; Sensato FR; Moreira DR; Pereira VR; Neves JK; de Oliveira AP; de Oliveira BC; Leite AC
J Enzyme Inhib Med Chem; 2014 Apr; 29(2):230-6. PubMed ID: 23432595
[TBL] [Abstract][Full Text] [Related]
2. Optimization of anti-Trypanosoma cruzi oxadiazoles leads to identification of compounds with efficacy in infected mice.
dos Santos Filho JM; Moreira DR; de Simone CA; Ferreira RS; McKerrow JH; Meira CS; Guimarães ET; Soares MB
Bioorg Med Chem; 2012 Nov; 20(21):6423-33. PubMed ID: 23006639
[TBL] [Abstract][Full Text] [Related]
3. Expanding the family of heteroleptic oxidovanadium(IV) compounds with salicylaldehyde semicarbazones and polypyridyl ligands showing anti-Trypanosoma cruzi activity.
Scalese G; Benítez J; Rostán S; Correia I; Bradford L; Vieites M; Minini L; Merlino A; Coitiño EL; Birriel E; Varela J; Cerecetto H; González M; Pessoa JC; Gambino D
J Inorg Biochem; 2015 Jun; 147():116-25. PubMed ID: 25824466
[TBL] [Abstract][Full Text] [Related]
4. Conformational restriction of aryl thiosemicarbazones produces potent and selective anti-Trypanosoma cruzi compounds which induce apoptotic parasite death.
Magalhaes Moreira DR; de Oliveira AD; Teixeira de Moraes Gomes PA; de Simone CA; Villela FS; Ferreira RS; da Silva AC; dos Santos TA; Brelaz de Castro MC; Pereira VR; Leite AC
Eur J Med Chem; 2014 Mar; 75():467-78. PubMed ID: 24561675
[TBL] [Abstract][Full Text] [Related]
5. Phenothiazine inhibitors of trypanothione reductase as potential antitrypanosomal and antileishmanial drugs.
Chan C; Yin H; Garforth J; McKie JH; Jaouhari R; Speers P; Douglas KT; Rock PJ; Yardley V; Croft SL; Fairlamb AH
J Med Chem; 1998 Jan; 41(2):148-56. PubMed ID: 9457238
[TBL] [Abstract][Full Text] [Related]
6. Computational and Investigative Study of Flavonoids Active Against Typanosoma cruzi and Leishmania spp.
Ribeiro FF; Junior FJ; da Silva MS; Scotti MT; Scotti L
Nat Prod Commun; 2015 Jun; 10(6):917-20. PubMed ID: 26197515
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of a new series of 3,5-disubstituted isoxazoles active against Trypanosoma cruzi and Leishmania amazonensis.
da Rosa R; de Moraes MH; Zimmermann LA; Schenkel EP; Steindel M; Bernardes LSC
Eur J Med Chem; 2017 Mar; 128():25-35. PubMed ID: 28152426
[TBL] [Abstract][Full Text] [Related]
8. Metal-based compounds as prospective antileishmanial agents: inhibition of trypanothione reductase by selected gold complexes.
Colotti G; Ilari A; Fiorillo A; Baiocco P; Cinellu MA; Maiore L; Scaletti F; Gabbiani C; Messori L
ChemMedChem; 2013 Oct; 8(10):1634-7. PubMed ID: 24039168
[TBL] [Abstract][Full Text] [Related]
9. In silico identification and evaluation of new Trypanosoma cruzi trypanothione reductase (TcTR) inhibitors obtained from natural products database of the Bahia semi-arid region (NatProDB).
da Paixão VG; Pita SSDR
Comput Biol Chem; 2019 Apr; 79():36-47. PubMed ID: 30710804
[TBL] [Abstract][Full Text] [Related]
10. Structural design, synthesis and structure-activity relationships of thiazolidinones with enhanced anti-Trypanosoma cruzi activity.
Moreira DR; Leite AC; Cardoso MV; Srivastava RM; Hernandes MZ; Rabello MM; da Cruz LF; Ferreira RS; de Simone CA; Meira CS; Guimaraes ET; da Silva AC; dos Santos TA; Pereira VR; Soares MB
ChemMedChem; 2014 Jan; 9(1):177-88. PubMed ID: 24203393
[TBL] [Abstract][Full Text] [Related]
11. Scorpiand-like azamacrocycles prevent the chronic establishment of Trypanosoma cruzi in a murine model.
Olmo F; Marín C; Clares MP; Blasco S; Albelda MT; Soriano C; Gutiérrez-Sánchez R; Arrebola-Vargas F; García-España E; Sánchez-Moreno M
Eur J Med Chem; 2013; 70():189-98. PubMed ID: 24158012
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological evaluation of new potent 5-nitrofuryl derivatives as anti-Trypanosoma cruzi agents. Studies of trypanothione binding site of trypanothione reductase as target for rational design.
Aguirre G; Cabrera E; Cerecetto H; Di Maio R; González M; Seoane G; Duffaut A; Denicola A; Gil MJ; Martínez-Merino V
Eur J Med Chem; 2004 May; 39(5):421-31. PubMed ID: 15110968
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of 4'-(2-ferrocenyl)-2,2':6'2''-terpyridine: characterization and antiprotozoal activity of Mn(II), Co(II), Ni(II), Cu(II) and Zn(II) complexes.
Juneja A; Macedo TS; Magalhaes Moreira DR; Pereira Soares MB; Lima Leite AC; Kelle de Andrade Lemoine Neves J; Alves Pereira VR; Avecilla F; Azam A
Eur J Med Chem; 2014 Mar; 75():203-10. PubMed ID: 24534536
[TBL] [Abstract][Full Text] [Related]
14. A new series of heteroleptic oxidovanadium(IV) compounds with phenanthroline-derived co-ligands: selective Trypanosoma cruzi growth inhibitors.
Fernández M; Varela J; Correia I; Birriel E; Castiglioni J; Moreno V; Costa Pessoa J; Cerecetto H; González M; Gambino D
Dalton Trans; 2013 Sep; 42(33):11900-11. PubMed ID: 23787783
[TBL] [Abstract][Full Text] [Related]
15. Trypanosoma cruzi trypanothione reductase inhibitors: phenothiazines and related compounds modify experimental Chagas' disease evolution.
Rivarola HW; Paglini-Oliva PA
Curr Drug Targets Cardiovasc Haematol Disord; 2002 Jun; 2(1):43-52. PubMed ID: 12769656
[TBL] [Abstract][Full Text] [Related]
16. A class of sulfonamides with strong inhibitory action against the α-carbonic anhydrase from Trypanosoma cruzi.
Güzel-Akdemir Ö; Akdemir A; Pan P; Vermelho AB; Parkkila S; Scozzafava A; Capasso C; Supuran CT
J Med Chem; 2013 Jul; 56(14):5773-81. PubMed ID: 23815159
[TBL] [Abstract][Full Text] [Related]
17. Ruthenium complexes endowed with potent anti-Trypanosoma cruzi activity: Synthesis, biological characterization and structure-activity relationships.
Donnici CL; Araújo MH; Oliveira HS; Moreira DR; Pereira VR; de Assis Souza M; de Castro MC; Leite AC
Bioorg Med Chem; 2009 Jul; 17(14):5038-43. PubMed ID: 19539479
[TBL] [Abstract][Full Text] [Related]
18. Parallel synthesis of a library of 1,4-naphthoquinones and automated screening of potential inhibitors of trypanothione reductase from Trypanosoma cruzi.
Salmon-Chemin L; Lemaire A; De Freitas S; Deprez B; Sergheraert C; Davioud-Charvet E
Bioorg Med Chem Lett; 2000 Apr; 10(7):631-5. PubMed ID: 10762041
[TBL] [Abstract][Full Text] [Related]
19. New therapeutic targets for drug design against Trypanosoma cruzi, advances and perspectives.
Rivera G; Bocanegra-García V; Ordaz-Pichardo C; Nogueda-Torres B; Monge A
Curr Med Chem; 2009; 16(25):3286-93. PubMed ID: 19548870
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Trypanosoma cruzi trypanothione reductase by crystal violet.
Moreno SN; Carnieri EG; Docampo R
Mol Biochem Parasitol; 1994 Oct; 67(2):313-20. PubMed ID: 7870135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]